Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph M McCune

Showing results (151-160 of 162) with videos related to

Pageof 17
Sort By:
Plos Pathogens|October 17, 2013
Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllersHiroyu Hatano, Steven A Yukl, April L Ferre, et al.
Science (New York, N.Y.)|January 17, 2004
Public health. A sound rationale needed for phase III HIV-1 vaccine trialsDennis R Burton, Ronald C Desrosiers, Robert W Doms, et al.
Plos Pathogens|May 17, 2014
HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortalitySergio Serrano-Villar, Talia Sainz, Sulggi A Lee, et al.
The Journal of Clinical Investigation|June 21, 2016
IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infectionSouheil-Antoine Younes, Michael L Freeman, Joseph C Mudd, et al.
Plos Pathogens|January 19, 2021
Relationship between CD4 T cell turnover, cellular differentiation and HIV persistence during ARTCharline Bacchus-Souffan, Mark Fitch, Jori Symons, et al.
Pathogens & Immunity|October 27, 2025
Meeting Summary for Keystone Symposia on HIV Cure: Antiretroviral Therapy (ART)-Free Control of HIV Infection in Durban, South Africa, 2025Kiho Tanaka, Tatenda Jimmy Blessing Chikowore, Steven G Deeks, et al.
The Journal of Experimental Medicine|November 13, 2008
Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infectionR Brad Jones, Lishomwa C Ndhlovu, Jason D Barbour, et al.
JCI Insight|December 22, 2020
TCF-1 regulates HIV-specific CD8+ T cell expansion capacityRachel L Rutishauser, Christian Deo T Deguit, Joseph Hiatt, et al.
Nature Medicine|October 3, 2017
Defining total-body AIDS-virus burden with implications for curative strategiesJacob D Estes, Cissy Kityo, Francis Ssali, et al.
Plos Medicine|November 8, 2017
HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational studyTimothy J Henrich, Hiroyu Hatano, Oliver Bacon, et al.
Pageof 17

Showing results (151-160 of 162) with videos related to

Sort By:
Pageof 17
Plos Pathogens|October 17, 2013
Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllersHiroyu Hatano, Steven A Yukl, April L Ferre, et al.
Science (New York, N.Y.)|January 17, 2004
Public health. A sound rationale needed for phase III HIV-1 vaccine trialsDennis R Burton, Ronald C Desrosiers, Robert W Doms, et al.
Plos Pathogens|May 17, 2014
HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortalitySergio Serrano-Villar, Talia Sainz, Sulggi A Lee, et al.
The Journal of Clinical Investigation|June 21, 2016
IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infectionSouheil-Antoine Younes, Michael L Freeman, Joseph C Mudd, et al.
Plos Pathogens|January 19, 2021
Relationship between CD4 T cell turnover, cellular differentiation and HIV persistence during ARTCharline Bacchus-Souffan, Mark Fitch, Jori Symons, et al.
Pathogens & Immunity|October 27, 2025
Meeting Summary for Keystone Symposia on HIV Cure: Antiretroviral Therapy (ART)-Free Control of HIV Infection in Durban, South Africa, 2025Kiho Tanaka, Tatenda Jimmy Blessing Chikowore, Steven G Deeks, et al.
The Journal of Experimental Medicine|November 13, 2008
Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infectionR Brad Jones, Lishomwa C Ndhlovu, Jason D Barbour, et al.
JCI Insight|December 22, 2020
TCF-1 regulates HIV-specific CD8+ T cell expansion capacityRachel L Rutishauser, Christian Deo T Deguit, Joseph Hiatt, et al.
Nature Medicine|October 3, 2017
Defining total-body AIDS-virus burden with implications for curative strategiesJacob D Estes, Cissy Kityo, Francis Ssali, et al.
Plos Medicine|November 8, 2017
HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational studyTimothy J Henrich, Hiroyu Hatano, Oliver Bacon, et al.
Pageof 17